Brief: Medistim's technology has achieved reimbursement in Japan

Medistim ASA

30/06/2016 09:48

June 30 (Reuters) - Medistim ASA  MEDS.OL : 
    * Medistim's technology has achieved reimbursement in Japan 
    * Valid from April 1, 2016, Ministry of Health, Labour and Welfare in Japan approved a 
reimbursement of YEN 25,000 [EUR 225] when blood flow of the graft is controlled, using either 
transit time flow measurement or high-resolution epicardial ultrasonography intraoperatively 
 
     
Source text for Eikon:  ID:nObiKYqMxa  
     
Further company coverage:  MEDS.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))